Skip to main content
Premium Trial:

Request an Annual Quote

Spotfire Links Software with IDBS and OxMol

Premium

CAMBRIDGE, Mass.--Spotfire has announced two separate integration agreements with IDBS of Guildford, UK, and Oxford Molecular Group. With IDBS, Spotfire will link its decision support software to the company's drug discovery data management system, ActivityBase, thus enabling scientists to access discovery data in ActivityBase, perform detailed analyses of the data, and distribute their findings to colleagues via Spotfire software in addition to the decision support tools within ActivityBase. In a similar arrangement, Spotfire will provide access to Oxford Molecular's RS3 Discovery database to allow scientists and cheminformatics personnel to access biological activity and chemical structure data stored in RS3 for interactive exploration and analysis in Spotfire Structure Visualizer and Spotfire Pro. The arrangement extends both companies' decision support offerings for the cheminformatics segment of pre-clinical drug discovery.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.